Opaleye Management Inc. Eton Pharmaceuticals, Inc. Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
A detailed history of Opaleye Management Inc. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 2,395,000 shares of ETON stock, worth $11 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
2,395,000
Previous 2,445,781
2.08%
Holding current value
$11 Million
Previous $9.17 Million
14.09%
% of portfolio
2.02%
Previous 2.23%
Shares
20 transactions
Others Institutions Holding ETON
# of Institutions
47Shares Held
8.16MCall Options Held
41KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA1.03MShares$4.72 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT941KShares$4.32 Million0.21% of portfolio
-
Westside Investment Management, Inc.585KShares$2.69 Million0.44% of portfolio
-
Acuitas Investments, LLC580KShares$2.66 Million1.08% of portfolio
-
Paradigm Capital Management Inc300KShares$1.38 Million0.05% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $116M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...